Net Peptide Content vs Purity: Two Different Numbers

A vial can be 99 percent pure and still contain substantially less peptide than the label claims. That statement is not a paradox. It follows directly from the fact that chromatographic purity and net peptide content measure different things, using different methods, and neither figure can be derived from the other. Every certificate that reports only one of these numbers is describing only part of the picture.

Two questions, not one

Purity asks: of all the UV-absorbing material in this sample that is peptide-related, what fraction is the target sequence? Net peptide content asks: of everything in this vial by mass, including counterions, water, and residual solvents, what fraction is actual peptide?

The first question is answered by chromatography. The second is answered by a separate assay, either amino acid analysis or nitrogen determination. The two measurements are independent. A sample with 99% HPLC purity could have net peptide content anywhere from roughly 50 to 95 percent, depending on sequence length, number of basic residues, salt form, and how the lyophilised powder has been handled. A single number cannot be inferred from the other.

That independence is the core point. Researchers and purchasers who read purity as a proxy for content are working with an incomplete interpretation of the data.

What HPLC area-percent purity actually measures

Reversed-phase HPLC separates the components of a peptide sample by hydrophobicity, eluting them sequentially into a UV detector. At around 214 to 220 nm, every amide bond in a peptide backbone absorbs ultraviolet light through an electronic transition in its carbonyl group. The detector records the intensity of that absorption over time as each species passes through the flow cell, and software integrates the area under each peak.

Purity by area-percent is then calculated as the area of the main target peak divided by the sum of all peptide-related peak areas, multiplied by 100. A result of 99% means that 99 out of every 100 units of integrated UV signal came from the target sequence, with the remaining 1% distributed across deletion sequences, truncated forms, or other synthesis-related impurities.

What that figure does not include: anything that does not produce a meaningful UV peak. Trifluoroacetate does not absorb meaningfully at 214 nm. Water does not. Residual acetonitrile from preparation elutes early in the run and is typically excluded from the purity integration window. These components are genuinely present in the vial. They are simply invisible to the UV detector in the context of a peptide purity calculation.

A purity figure without the method beside it is an incomplete statement, because the method determines the number. Area-percent purity at 214 nm is the most common convention in this field, but it is a convention, not a universal definition. A certificate that reports a number and names no method has quietly removed the ability of anyone to check it.

What fills the rest of the vial

Three main components account for the mass that is not peptide.

TFA counterion. Solid-phase peptide synthesis uses trifluoroacetic acid in the deprotection and cleavage steps. The peptide is cleaved from the resin in TFA and emerges from preparative HPLC purification as a trifluoroacetate salt. The trifluoroacetate ion carries a molecular weight of approximately 114 g/mol and binds to the basic sites on the peptide backbone, principally the free N-terminus and the side chains of lysine, arginine, and histidine. A peptide with several such sites can carry multiple trifluoroacetate ions per molecule. The mass contribution is not trivial. For a peptide sequence with four or five basic residues, the TFA salt form alone can account for 20 percent or more of the total powder mass.

Residual water. Lyophilised peptides are hygroscopic. Even after freeze-drying, a measurable quantity of water remains bound within the powder matrix. Karl Fischer titration of lyophilised pharmaceutical preparations typically finds residual moisture in the range of 0.5 to approximately 3 percent by weight. Commercial peptide powders, particularly those not stored under desiccant or opened to ambient air, can absorb additional moisture from the atmosphere before or after dispatch.

Residual solvents and other salts. Trace quantities of acetonitrile, isopropanol, or acetic acid from the purification and lyophilisation process may persist. Their individual contributions are generally small but form part of the total mass balance.

The mass balance of a fully characterised peptide powder should sum to 100 percent: net peptide content plus counterion content plus water content plus trace solvents equals the total weighed mass. Most commercial certificates do not present all four components.

Worked logic: how 99 percent pure becomes 75 percent content

Consider a hypothetical peptide with five basic residues, purified as a TFA salt. A reasonable set of numbers might look like this.

• HPLC purity: 99.1% by area-percent at 214 nm
• TFA counterion mass: approximately 20 to 25% of total powder weight
• Residual water: approximately 2 to 4% of total powder weight
• Net peptide content: approximately 72 to 78%

These figures do not contradict one another. The HPLC tells you that nearly all of the peptide in the vial is the correct sequence. The content assay tells you that roughly three-quarters of the powder mass is peptide of any kind. Both statements are accurate descriptions of the same vial.

The practical implication is direct. If a researcher assumes that a vial labelled 5 mg contains 5 mg of peptide, and the net peptide content is 75%, the actual peptide mass is approximately 3.75 mg. A solution prepared on the basis of the labelled mass will be approximately 25% less concentrated than intended. For research applications where dose precision matters, the gap between labelled mass and actual peptide mass is consequential.

Amino acid analysis: the primary method

Quantitative amino acid analysis (AAA) is the most widely used method for determining net peptide content. The process has three stages.

First, the peptide is hydrolysed under acidic conditions, typically in 6 M hydrochloric acid at around 110 degrees Celsius for 20 to 70 hours, depending on the protocol. This breaks every peptide bond and releases the constituent amino acids as free molecules.

Second, the free amino acids are separated and quantified by HPLC, usually following derivatisation with a reagent such as ninhydrin or a fluorescent tag that allows sensitive detection. Each amino acid is identified and quantified against calibration standards of known concentration.

Third, the measured quantities of each amino acid are used to calculate the mass of intact peptide that was present in the original sample, based on the known sequence and the theoretical amino acid composition.

The critical advantage of AAA is that counterions, water, and residual solvents do not contribute to the calculated value. Only the amino acid-derived signal from the peptide itself is counted. The result is expressed as mass of peptide per mass of sample, and then as a percentage. Residual water, salts, and counterions are not amino acids; they do not generate a signal in the AAA quantification and are therefore not counted in the result.

AAA is considered the reference method for net peptide content. It is demanding in terms of instrument time and requires careful hydrolysis and calibration to avoid artefacts such as destruction of susceptible amino acids during acid hydrolysis. Cysteine and tryptophan, for instance, are partially destroyed under standard acid hydrolysis conditions and require modified protocols for accurate recovery.

Nitrogen determination as an alternative

A complementary approach is total nitrogen determination. All amino acids contain nitrogen in their backbone, and the nitrogen content of a given peptide sequence is calculable from its composition. By measuring the total organic nitrogen in a weighed sample and comparing it to the theoretical nitrogen content per unit mass of that sequence, the analyst can back-calculate the peptide mass present.

The Dumas combustion method, also called CHNS elemental analysis, combusts the sample completely in a high-temperature, oxygen-rich environment. The resulting nitrogen oxides are reduced to molecular nitrogen, which is then quantified by thermal conductivity detection. The Dumas method is faster and less chemically hazardous than the classical Kjeldahl approach, which achieves the same conversion through wet acid digestion followed by distillation and titration of the liberated ammonia.

Nitrogen determination has one limitation specific to peptide content work: any non-peptide nitrogen-containing compound in the sample, such as an ammonium salt or a nitrogen-containing buffer residue, will contribute to the measured nitrogen and inflate the apparent peptide content. For clean, well-characterised samples, the method is reliable. For samples of uncertain provenance, it is prudent to corroborate with AAA.

Salt form and counterion exchange

Because the counterion contributes real mass, the reported net peptide content of a sample is bound to the salt form in which it was analysed. The same peptide sequence, analysed as a TFA salt versus an acetate salt, will yield different net peptide content figures by weight, because trifluoroacetate (approximately 114 g/mol) is approximately twice the mass of acetate (approximately 59 g/mol).

Ion exchange from TFA to acetate is a routine step in pharmaceutical peptide manufacturing, performed by dissolving the TFA salt in dilute acetic acid and re-lyophilising. The process replaces the heavier counterion with the lighter one, increasing net peptide content by weight without altering the peptide sequence or its chromatographic purity.

For a certificate to be interpretable, it should state the salt form alongside the net peptide content figure. A content value of 78% for a TFA salt and 85% for the same sequence as an acetate salt are both correct. They are simply characterisations of different material presentations. Comparing them without noting the salt form leads to incorrect conclusions.

Why the number is usually absent

Net peptide content is routinely absent from commercial certificates. The reasons are practical rather than analytical. AAA and nitrogen determination add time and cost to an analysis run. HPLC purity and mass spectrometry identity confirmation are faster, cheaper, and sufficient to demonstrate that the correct sequence has been purified to a stated grade. Many suppliers and testing arrangements stop there.

The result is that purchasers receive a partial characterisation. Purity tells them the sequence is correct and reasonably free of truncations or deletions. It says nothing about how much of the powder mass is that peptide. For research applications where reconstitution at a precise concentration is important, a certificate missing the content figure leaves a genuine gap.

Net peptide content must be requested by name. It is not inferred from purity, not estimated from the labelled mass, and not derivable from mass spectrometry data. When a certificate presents only an area-percent purity figure and a mass spectrum, it is an incomplete description of the material for any work that depends on knowing the actual peptide dose.

A third-party analytical laboratory, separated from the supplier, has no incentive to omit the measurement if asked for it. Novagen reports what was measured in the sample submitted. Certificates are listed on the public register at novagenlaboratories.com. Enquiries, including requests for net peptide content as part of a testing submission, can be directed to admin@novagenlaboratories.com. Current quoted turnaround is 21 days from receipt of samples.

Reading both numbers together

The two figures complement each other. A high purity value with a low net peptide content tells a specific story: the peptide that is present is the right sequence, but a large fraction of the vial mass is counterion or water. A lower purity value with a higher net peptide content tells a different story: most of the mass is peptide, but a meaningful portion of that peptide is impurity sequences.

For most research purposes, the first scenario is preferable, because the impurities in the second scenario are other peptide sequences that may have their own biological activity. But neither scenario can be understood at all from a single purity number. Both measurements belong on a complete certificate.

The broader principle is that a certificate describes the sample submitted and nothing beyond it. Purity is a statement about composition within the peptide fraction. Net peptide content is a statement about the mass fraction of peptide within the total material. Safety, efficacy, stability, and suitability for a given application are separate questions that a certificate does not answer. What a complete certificate does do is give the analyst the numbers they need to make those judgements with accurate inputs.

For further context on what HPLC area-percent purity represents and how to interpret individual peaks, see What 99 Percent Purity Means, How to Read a Peptide Certificate of Analysis, and Peak Area and Purity.